Health
Horizon Discovery licenses CHOSOURCE to Sanyou Biopharmaceuticals Co. – News-Medical.net
Horizon Discovery today announced that it has granted commercial licenses for its cGMP-compliant CHOSOURCE™ platform to Sanyou Biopharmaceuticals.
Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that it has granted two commercial licenses for its cGMP-compliant CHOSOURCE™ platform to Sanyou Biopharmaceuticals Co., Ltd., a leading biotechnology company focused on research, development and providing integrated solutions for innovative antibody drug developments.
Sanyou will use Horizon’s gene-edited Glutamine Synthetase (GS) knockout Chinese Hamster…
-
General20 hours agoCalifornia worker dead and hundreds arrested after cannabis farm raid
-
Noosa News19 hours agoUnlawful wounding charges, Caloundra – Sunshine Coast
-
General23 hours agoWallaroos fall to Black Ferns 37-12 in Wellington Test
-
General12 hours agoWest Indies-Australia live: Third day-night Test in Jamaica